五月婷婷丁香-91看片在线观看-久久精品黄色-青青青在线-欧美国产日韩视频-性free毛茸茸videos-国产欧美亚洲精品-色视频网站在线观看-全国免费av-在线免费看av的网站-色黄啪啪网-国产精品vip-国产精品福利av-黄上黄在线观看-福利成人导航

The center has a pharmaceutical chemistry department, a macromolecular biology department, a pharmacology department, a pharmacy department and a non-clinical department. It is mainly based on its own early discovery and druggability evaluation and screening system, combined with solid pharmaceutical development and expert resources, through investment, shareholding, Various models such as service shareholding and joint entrepreneurship are used to incubate various innovative drug projects and enhance the long-term imagination and value space of Baicheng Pharmaceutical's innovative drug sector in multiple dimensions. At present, the company is involved in the main aspects of innovative drug research and development such as new drug discovery, lead compound optimization, preclinical development, clinical registration application, and phase 1 clinical trials. It has multiple innovative drug projects under development, one of which has entered clinical phase 1 research (obtained the 2020 Project support from Zhejiang Provincial Key R&D Plan).